Skip to main navigation Skip to search Skip to main content

Soluble receptor of advanced glycation end products (sRAGE) indicates response to chemotherapy in pancreatic cancer patients

  • Christin Wittwer
  • , Stefan Boeck
  • , Volker Heinemann
  • , Michael Haas
  • , Petra Stieber
  • , Dorothea Nagel
  • , Stefan Holdenrieder
  • Ludwig-Maximilians-Universität München
  • University of Bonn and University Hospital Bonn

Research output: Contribution to journalArticlepeer-review

8 Scopus citations
Original languageEnglish
Pages (from-to)67-69
Number of pages3
JournalInternational Journal of Clinical Pharmacology and Therapeutics
Volume51
Issue number1
DOIs
StatePublished - Jan 2013
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • HMBG1
  • Immunogenic cell death
  • Pancreatic cancer
  • Tumor markers
  • sRAGE

Cite this